March 04, 2025

Francis S. Collins, MD, PhD, Retires From the National Institutes of Health

Francis S. Collins, MD, PhD, announced in a statement his retirement as Director of the National Institutes of Health (NIH), effective February 28, 2025. Dr. Collins is the longest-serving presidentia...

The ASCO Post

January 18, 2023

Interventions to Improve Advanced Practitioner Work-Related Quality of Life and Patient Satisfaction

Background: Across the United States, an incremental need for cancer care continues to emerge. Specialty nurse practitioners and physician assistant teams have helped in meeting this demand. However, ...

JADPRO

March 22, 2023

Using Pleomorphic Adenoma Gene 1 (PLAG1) to Distinguish Carcinoma of the Parotid Gland From Primary Lung Cancer: A Case Study

A 40-year-old female never-smoker with no significant medical history presented with right-side facial swelling and 3 months of progressive, radiating otalgia. This article reviews the case of a young...

JADPRO

March 22, 2023

The Importance of Professional Communities and Collaborations

The complexity of cancer care requires unique skill sets that must be cultivated. Collaborating with professionals specializing in different areas ensures comprehensive and patient-centered care. A mu...

JADPRO

July 17, 2023

Providing Care During Cancer Drug Shortages

Drug shortages have become a global phenomenon, reaching an all-time high and affecting nearly every therapeutic area of medicine. Even short-term drug shortages cause deleterious effects in critical ...

JADPRO

April 24, 2023

What Does Dobbs v. Jackson Mean for Oncology Patients and Providers? Current Considerations for Pregnancy and Fertility in the Oncology Setting

The incidence of cancers such as colorectal cancer, head and neck cancer, and melanoma has increased in younger patients. The number of cancer survivors is also increasing in the US. Pairing these fac...

JADPRO

March 22, 2023

Convergence of Hematology and Rheumatology: A Case Study

Advanced practitioners may frequently encounter patients who have a hematologic and rheumatologic diagnosis. These patients are usually managed by multiple specialists, including hematologists, rheuma...

JADPRO

May 23, 2023

Management of Ocular Toxicity in Patients Receiving Belantamab Mafodotin

While significant strides have been made in the treatment of multiple myeloma, treatment options remain limited and definite, and most patients ultimately succumb to their disease. The urgency for mor...

JADPRO

September 18, 2023

‘My Choices, My Wishes’ Program and Its Effect on Chemotherapy at the End of Life and Advance Care Directive Documentation

Explore the evolving landscape of oncology care, focusing on goal-concordant treatment and the integration of palliative care for improved patient outcomes and quality of life.

JADPRO